Literature DB >> 23777700

Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries.

L H De Oliveira1, N Giglio, A Ciapponi, S García Martí, M Kuperman, N J Sanwogou, C Ruiz-Matus, M F Marinho de Sousa.   

Abstract

INTRODUCTION: Rotavirus infection mainly affects children under 5 years of age and causes 453,000 deaths annually throughout the world. Several countries in Latin America have introduced the rotavirus vaccine and the majority have epidemiological data to measure impact following vaccine introduction.
OBJECTIVE: To assess the impact of rotavirus immunization on the number of all-cause diarrhea-related deaths and hospitalizations in children under 1 and 5 years of age in Bolivia, El Salvador, Honduras and Venezuela.
METHODS: Interrupted time-series analyzed with the integral method and the projection method to evaluate the pre and post-vaccine introduction trend in diarrheal disease compared to Argentina as the control country. The analysis period was from 2002 to 2010, including 2 to 4 post-vaccine years depending on the country. Information sources included records from PAHO, the Ministry of Health, public hospitals, social security, the private health system, the Expanded Programme on Immunization and UNPop 2008.
RESULTS: Over the period studied, reductions were observed in trends of diarrhea-related deaths and hospitalizations in children under five. In diarrhea-related deaths, under the integral method, the range of reduction was between 15.7% (13.5-17.9) and 56.8% (56.0-57.5) while with the projection method was between 19.9% (4.9-34.8) and 63.7%(56.1-71.4). In diarrhea-related hospitalizations, under the integral method was 5.6% (4.1-6.7) and 17.9% (16.7-19.1)) while with the projection method was between 5.1%(1.7-8.7) and 11.1% (5.8-16.3)
CONCLUSIONS: A decrease was observed in the number of diarrhea related deaths and hospitalizations in all countries under study following introduction of the rotavirus vaccine as opposed to the control country. The impact on reduction of deaths was greater than hospitalization.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777700     DOI: 10.1016/j.vaccine.2013.05.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Association of Anti-Rotavirus IgA Seroconversion with Growth, Environmental Enteric Dysfunction and Enteropathogens in Rural Pakistani Infants.

Authors:  Sheraz Ahmed; Junaid Iqbal; Kamran Sadiq; Fayaz Umrani; Arjumand Rizvi; Furqan Kabir; Zehra Jamil; Sana Syed; Lubaina Ehsan; Fatima Zulqarnain; Muhammed Sajid; Aneeta Hotwani; Najeeb Rahman; Jennie Z Ma; Monica McNeal; Sue Ann Costa Clemens; Najeeha Talat Iqbal; Sean R Moore; Asad Ali
Journal:  Vaccine       Date:  2022-05-06       Impact factor: 4.169

3.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

4.  Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013-2014.

Authors:  Kimberly D Pringle; Maritza Patzi; Jacqueline E Tate; Volga Iniguez Rojas; Manish Patel; Lucia Inchauste Jordan; Raul Montesano; Adolfo Zarate; Lucia De Oliveira; Umesh Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 20.999

5.  Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination.

Authors:  Ricardo Q Gurgel; Alberto De Juan Alvarez; Alda Rodrigues; Robergson R Ribeiro; Sílvio S Dolabella; Natanael L Da Mota; Victor S Santos; Miren Iturriza-Gomara; Nigel A Cunliffe; Luis E Cuevas
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

6.  Methods and challenges for the health impact assessment of vaccination programs in Latin America.

Authors:  Ana Marli Christovam Sartori; Andréia de Fátima Nascimento; Tânia Yuka Yuba; Patrícia Coelho de Soárez; Hillegonda Maria Dutilh Novaes
Journal:  Rev Saude Publica       Date:  2016-01-15       Impact factor: 2.106

7.  Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

Authors:  Casey L McAtee; Rachel Webman; Robert H Gilman; Carolina Mejia; Caryn Bern; Sonia Apaza; Susan Espetia; Mónica Pajuelo; Mayuko Saito; Roxanna Challappa; Richard Soria; Jose P Ribera; Daniel Lozano; Faustino Torrico
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

8.  Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Authors:  Sheila Isanaka; Céline Langendorf; Monica Malone McNeal; Nicole Meyer; Brian Plikaytis; Souna Garba; Nathan Sayinzoga-Makombe; Issaka Soumana; Ousmane Guindo; Rockyiath Makarimi; Marie Francoise Scherrer; Eric Adehossi; Iza Ciglenecki; Rebecca F Grais
Journal:  PLoS Med       Date:  2021-07-02       Impact factor: 11.069

Review 9.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

10.  Characterisation of a rare, reassortant human G10P[14] rotavirus strain detected in Honduras.

Authors:  Osbourne Quaye; Sunando Roy; Kunchala Rungsrisuriyachai; Mathew D Esona; Ziqian Xu; Ka Ian Tam; Dina J Castro Banegas; Gloria Rey-Benito; Michael D Bowen
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-01       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.